Global Radiotherapy Market Expected to Reach USD 9.9 Billion by 2033, with North America Leading at 35.8% Market Share in 2024 - IMARC Group

Global Radiotherapy Market Statistics, Outlook and Regional Analysis 2025-2033

The global radiotherapy market size was valued at USD 7.1 Billion in 2024, and it is expected to reach USD 9.9 Billion by 2033, exhibiting a growth rate (CAGR) of 3.8% from 2025 to 2033.

Advanced radiation solutions are transforming cancer care throughout the world, with investments in cutting-edge technologies such as linear accelerators and precise instruments increasing treatment results. These advancements show a growing commitment to improving access to effective and cutting-edge medicines and reducing the cancer burden. For example, in August 2024, Elekta announced that it received a USD 64 Million order from the Hospital Angeles Health System in Mexico for advanced linear accelerators and the company's Elekta Esprit Gamma Knife. The agreement would improve cancer treatment throughout Mexico, concentrating on novel radiation methods and demonstrating the hospital's dedication to effectively addressing the country's cancer burden.

Moreover, collaborations in targeted radiation are expanding cancer treatment worldwide, with an emphasis on innovative isotope-based treatments for solid tumors. These partnerships demonstrate the increased emphasis on precision medicine, which enables more effective and targeted methods to tackle complicated cancer concerns. For instance, in October 2024, Eckert & Ziegler SE, a nuclear medicine leading supplier of isotopes, announced entering into a global clinical supply agreement with GlyTherix Ltd, an Australian company focused on targeted radiotherapy for solid tumors. Furthermore, the market is growing rapidly, driven by the demand for more accurate and efficient cancer treatments. Vendors are concentrating on creating cutting-edge technologies such as image-guided and proton beam treatments to improve treatment results. This progress also creates considerable prospects in emerging nations where access to modern radiation equipment is limited. Additionally, high-performance radiation systems are becoming more popular among healthcare practitioners due to their precision and low side effects. For example, the need for innovative radiation technology in Europe has increased as the region focuses on improving cancer care. Elekta and Varian Medical Systems are introducing advanced technologies such as the Unity MR-Linac system, which combines imaging and treatment to improve accuracy. Hospitals in Germany and the U.K. have embraced these technologies, demonstrating the region's dedication to providing cutting-edge cancer treatment alternatives.

Global Radiotherapy Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest radiotherapy market share on account of well-established healthcare infrastructure, robust funding for cancer research, and high prevalence of cancer.

North America Radiotherapy Market Trends:

In 2024, North America holds the largest market share of over 35.8% owing to the rising cancer rates and technical advances in therapy. Proton treatment clinics are proliferating, with institutions such as the Mayo Clinic driving innovation. The U.S. is a prominent country in the market due to extensive government financing and research. For example, Varian Medical Systems launched HyperArc, a high-precision radiation system that improves treatment accuracy while lowering side effects, demonstrating the region's emphasis on cutting-edge cancer medicines.

Europe Radiotherapy Market Trends:

Europe prioritizes individualized radiotherapy, utilizing AI and machine intelligence to enhance treatment strategies. The growth of public-private partnerships has accelerated access to modern radiation equipment. For example, Elekta collaborated with numerous European hospitals to implement the Unity MR-Linac system, which allows for accurate imaging during therapy sessions. This adoption improves patient outcomes and is consistent with Europe's emphasis on technology innovation and accessible healthcare solutions.

Asia Pacific Radiotherapy Market Trends:

The market in Asia Pacific is expanding due to increased healthcare spending and knowledge of advanced cancer therapies. Countries such as China and India are quickly embracing linear accelerators. For example, Tata Memorial Hospital in India installed Elekta's Versa HD to increase cancer treatment access, demonstrating the region's efforts to improve infrastructure and extend radiation services in impoverished areas.

Latin America Radiotherapy Market Trends:

The market in Latin America is developing in response to measures aimed at improving cancer treatment access. Governments are investing in radiation facilities, especially in Brazil and Mexico. For example, the National Cancer Institute of Brazil has chosen Varian's Halcyon radiation system, which provides quicker and more efficient treatments. These advances are reducing regional inequities and improving cancer care delivery networks.

Middle East and Africa Radiotherapy Market Trends:

The market in the Middle East and Africa focuses on filling gaps in cancer-care infrastructure. The UAE leads the region in cutting-edge facilities, such as Dubai hospital's modern radiation center. Collaborations with multinational enterprises create cutting-edge solutions that improve treatment access and outcomes throughout the region. For example, GE Healthcare collaborated with African nations to extend radiation services, therefore meeting unmet healthcare needs.

Top Companies Leading in the Radiotherapy Industry

Some of the leading radiotherapy market companies include Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB, General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health), and Siemens Healthineers AG (Siemens AG), among many others. In August 2024, Accuray Incorporated announced that it received CE Mark approval for the Accuray Helix, a CT-guided helical radiotherapy system. The system is targeting emerging markets where limited access exists to advanced cancer care, filling in the shortfall of linear accelerators compared to WHO recommendations.

Global Radiotherapy Market Segmentation Coverage

• On the basis of the type, the market has been segmented into external beam radiation therapy (intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), tomotherapy, stereotactic radiosurgery, stereotactic body radiation therapy, proton therapy, 3D conformal radiotherapy (3D CRT), and volumetric modulated arc therapy (VMAT)), internal radiation therapy/brachytherapy, and systemic radiation therapy, wherein external beam radiation therapy represents the most preferred segment with around 62.0% of market share in 2024. The rising demand for external beam radiation therapy (EBRT) is driven by its versatility and effectiveness in accurately treating a wide range of tumors.
• Based on the application, the market is categorized into skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others, amongst which breast cancer dominates the market with around 28.8% of market share in 2024. Radiotherapy's effectiveness as an essential postoperative treatment method to prevent tumor recurrence in breast cancer.
• On the basis of the end user, the market has been divided into hospitals, cancer research institutes, and ambulatory and radiotherapy centers. Among these, ambulatory and radiotherapy centers exhibit a clear dominance in the market. Ambulatory and radiotherapy centers allow patients to obtain high-quality, specialized treatment without the requirement for overnight hospitalization.

Browse IMARC Related Reports on Radiotherapy Market:

• Japan Radiotherapy Market Report
   
• United States Radiotherapy Market Report